Fulgent Genetics, Inc.

Healthcare · Diagnostics & Research · United States

Last price 21.68 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 596.53M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company’s clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive he...